Medications

Sanofi acquires over-the-counter rights for Cialis

French drugmaker Sanofi is buying the rights to seek approval for a version of the erectile dysfunction drug Cialis that customers would be able to buy without a doctor's prescription.

Vaccination

Sanofi-GSK COVID booster jab shows positive results

French drug maker Sanofi said Monday a COVID booster shot it is developing with Britain's GlaxoSmithKline has produced positive results against Omicron and other variants in clinical trials.

Diseases, Conditions, Syndromes

Brazil authorizes dengue vaccine

Brazil became the first South American country Monday to authorize the world's first-ever dengue fever vaccine, which its French manufacturer says has the potential to save hundreds of lives here.

Medications

Sanofi sues Eli Lilly for patent infringement

French pharmaceutical giant Sanofi has said it is suing US rival Eli Lilly in an American court for infringing four patents relating to its diabetes treatments.

Diseases, Conditions, Syndromes

New dengue vaccine could worsen disease in some people

Drugmaker Sanofi says that its dengue vaccine, the world's first, should only be given to people who have previously been sickened by the virus, according to new long-term data.

Medical research

Small molecule helps get stem cells to sites of disease and damage

Bioengineers from Brigham and Women's Hospital (BWH) with collaborators at the pharmaceutical company Sanofi have identified small molecules that can be used to program stem cells to home in on sites of damage, disease and ...

Pediatrics

Positive trial results for RSV infant treatment: Sanofi

French pharmaceutical giant Sanofi announced trial results on Friday that showed its preventative treatment for respiratory syncytial virus (RSV) reduced the rate of babies being hospitalized by more than 80 percent.

page 3 from 13